Substance use & misuse · 2026
E-Cigarette Perceptions Among Adults with Recent Myocardial Infarction or Heart Failure Diagnosis: Population Assessment of Tobacco and Health Study, 2022-2023.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Selva Kumar Danusha, Lee Sharon Y, Gathright Emily
Аннотация
BACKGROUND: Smoking cessation is recommended for individuals with cardiovascular disease (CVD), but cigarette users with myocardial infarction (MI) or heart failure (HF) have difficulty in quitting smoking. The prevalence of e-cigarette use among individuals with MI or HF in recent years is unknown.
METHODS: We analyzed nationally representative data from the Population Assessment of Tobacco and Health Study (Wave 7) to assess prevalence of e-cigarette use, perceptions of harm from e-cigarettes, and interest in switching from cigarettes to e-cigarettes among individuals with a recent MI or HF diagnosis.
RESULTS: Among US adults with a MI or HF diagnosis in the previous year, 22.0% reported cigarette use only, 0.9% reported e-cigarette use only, and 2.7% reported dual cigarette and e-cigarette use. Of cigarette users, only 4.5% reported an interest in switching from cigarettes to e-cigarettes. More than two-thirds (70.2%) of participants perceived e-cigarettes as very or extremely harmful.
CONCLUSIONS: Cigarette users with a recent MI or HF diagnosis reported low interest in switching to e-cigarettes. The low interest, with the concerns about the harmful effects of e-cigarettes, suggests that switching from cigarettes to e-cigarettes may not be an acceptable strategy to reduce the risk of cigarette smoking in this population.
METHODS: We analyzed nationally representative data from the Population Assessment of Tobacco and Health Study (Wave 7) to assess prevalence of e-cigarette use, perceptions of harm from e-cigarettes, and interest in switching from cigarettes to e-cigarettes among individuals with a recent MI or HF diagnosis.
RESULTS: Among US adults with a MI or HF diagnosis in the previous year, 22.0% reported cigarette use only, 0.9% reported e-cigarette use only, and 2.7% reported dual cigarette and e-cigarette use. Of cigarette users, only 4.5% reported an interest in switching from cigarettes to e-cigarettes. More than two-thirds (70.2%) of participants perceived e-cigarettes as very or extremely harmful.
CONCLUSIONS: Cigarette users with a recent MI or HF diagnosis reported low interest in switching to e-cigarettes. The low interest, with the concerns about the harmful effects of e-cigarettes, suggests that switching from cigarettes to e-cigarettes may not be an acceptable strategy to reduce the risk of cigarette smoking in this population.